@article{shrestha_pathological_2021, title = {Pathological β-{Cell} {Endoplasmic} {Reticulum} {Stress} in {Type} 2 {Diabetes}: {Current} {Evidence}}, volume = {12}, issn = {1664-2392}, shorttitle = {Pathological β-{Cell} {Endoplasmic} {Reticulum} {Stress} in {Type} 2 {Diabetes}}, url = {https://www.frontiersin.org/articles/10.3389/fendo.2021.650158/full}, doi = {10.3389/fendo.2021.650158}, abstract = {The notion that in diabetes pancreatic β-cells express endoplasmic reticulum (ER) stress markers indicative of increased unfolded protein response (UPR) signaling is no longer in doubt. However, what remains controversial is whether this increase in ER stress response actually contributes importantly to the β-cell failure of type 2 diabetes (akin to ‘terminal UPR’), or whether it represents a coping mechanism that represents the best attempt of β-cells to adapt to changes in metabolic demands as presented by disease progression. Here an intercontinental group of experts review evidence for the role of ER stress in monogenic and type 2 diabetes in an attempt to reconcile these disparate views. Current evidence implies that pancreatic β-cells require a regulated UPR for their development, function and survival, as well as to maintain cellular homeostasis in response to protein misfolding stress. Prolonged ER stress signaling, however, can be detrimental to β-cells, highlighting the importance of “optimal” UPR for ER homeostasis, β-cell function and survival.}, urldate = {2021-09-07}, journal = {Frontiers in Endocrinology}, author = {Shrestha, Neha and De Franco, Elisa and Arvan, Peter and Cnop, Miriam}, month = apr, year = {2021}, keywords = {WP5}, pages = {650158}, }